David Jilich

HIV care in times of the COVID-19 crisis — Where are we now in Central and Eastern Europe?

Justyna Kowalska, Agata Skrzat‐Klapaczyńska, Dominik Bursa et al. · International Journal of Infectious Diseases · 2020 · 104 citations · Full text

Incidence, immunological and clinical characteristics of reactivation of latent<i>Toxoplasma gondii</i>infection in HIV-infected patients

Petr Kodym, Marek Malý, Ondřej Beran et al. · Epidemiology and Infection · 2014 · 62 citations · Full text

Immunodeficiencies, Immunology, Immunodominance +17

Development of 5‘ LTR DNA methylation of latent HIV-1 provirus in cell line models and in long-term-infected individuals

Kateřina Trejbalová, Denisa Kovářová, Jana Blažková et al. · Clinical Epigenetics · 2016 · 62 citations · Full text

Effect of immediate initiation of antiretroviral therapy on risk of severe bacterial infections in HIV-positive people with CD4 cell counts of more than 500 cells per μL: secondary outcome results from a randomised controlled trial

Jemma L. O’Connor, Michael J. Vjecha, Andrew Phillips et al. · The Lancet HIV · 2017 · 57 citations · Full text

HIV care in Central and Eastern Europe: How close are we to the target?

Deniz Gökengin, Cristiana Oprea, Josip Begovać et al. · International Journal of Infectious Diseases · 2018 · 56 citations · Full text